Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues
Reexamination Certificate
2007-05-15
2007-05-15
Campell, Bruce R. (Department: 1648)
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
C424S204100, C424S226100, C530S350000, C530S344000
Reexamination Certificate
active
10449531
ABSTRACT:
A pure, water-soluble polypeptide containing one or more monomers of a VP1 protein of a foot-and-mouth disease virus; or a pure, water-insoluble polypeptide comprising two or more monomers of a VP1 protein of a foot-and-mouth disease virus. Also disclosed are a vaccine containing the polypeptide, a method of producing the polypeptide, and a method of inducing an immune response in a subject by administering to the subject an effective amount of the polypeptide.
REFERENCES:
patent: 4620948 (1986-11-01), Builder et al.
patent: 4769237 (1988-09-01), Bittle et al.
Rueckert. Picornaviridae: The Viruses and Their Replication. In B.N. Fields et al. (ed.), Fields Virology, 3rd ed. Philadelphia: Lippencott-Raven Publishers; 1996; 615.
Knowles N. J. et al., Emergence in Asia of Foot-and-Mouth Disease Viruses with Altered Host Range: Characterization of Alterations in the 3A Protein. J. Virol. 2001 vol. 75, pp. 1551-1556.
NCBI Accession No. AJ294924—year 2001, (updated to show year).
N. R. Parry et al. “Neutralizing Epitopes of Type O Foot-and-Mouth Disease Virus. II. Mapping Three Conformational Sites with Synthetic Peptide Reagents”. J. Gen. Virol. 70:1493-1503, 1989.
D. McCahon et al. “Evidence for At Least Four Antigenic Sites on Type O Foot-and-Mouth Disease Virus Involved in Neutalization; Identification by Single and . . . ”. J. Gen. Virol. 70:639-645, 1989.
A. Villaverde et al. “A recombinant, arginine-glycine-aspartic acid (RGD) motif from foot-and-mouth disease virus binds mammalian cells through vitronectin and . . . ”. Gene 180:101-106, 1996.
T. Jackson et al. “Efficient Infection of Cells in Culture by Type O Foot-and-Mouth Disease Virus Requires Binding to Cell Surface Heparan . . . ”. Journal of Virology 70(8):5282-5287, Aug. 1996.
K. Strebel et al. “Characterization of Foot-and-Mouth Disease Virus Gene Products with Antisera Against Bacterially Synthesized Fusion Proteins”. Journal of Virology 57(3):983-991, Mar. 1986.
D. Kleid et al. “Cloned Viral Protein Vaccine for Foot-and-Mouth Disease: Responses in Cattle and Swine”. Science 214:1125-1129, Dec. 1981.
J. Chinsangaram et al. “Antibody Response in Mice Inoculated with DNA Expressing Foot-and-Mouth Disease Virus Capsid Proteins”. Journal of Virology 72(5):4454-4457, May 1998.
K. Bayry et al. “Immuno affinity purification of foot and mouth disease virus type specific antibodies using recombinant protein . . . ”. Journal of Virological Methods 81:21-30, 1999.
V.V.S. Suryanarayana et al. “Characterization and Immune Response of a Protein Produced by a cDNA Clone of Foot and Mouth . . . ”. Biochemistry International 26(6):1003-1016, May 1992.
V.D. Murdin et al. “Isolation of Capsid Proteins of Foot-and-Mouth Disease Virus by Chromatofocusing”. Journal of Virological Methods 207-216, 1983.
C.-C. Huang et al. “Anti-3AB antibodies in the Chinese yellow cattle infected by the O/Taiwan/99 foot-and-mouth disease virus”. Veterinary Microbiology 84:317-326, 2002.
M. Agterberg et al. “Protection of guinea-pings against foot-and-mouth disease virus by immunization with a PhoE-FMDV hybrid protein”. Vaccine 8:438-440, Oct. 1990.
T. Haack et al. “A cyclic disulfide peptide reproduces in solution the main structural features of a native antigenic . . . ”. International Journal of Biological Macromolecules 20:209-219, 1997.
E. Domingo et al. “Biochemical and structural studies with neutralizing antibodies raised against foot-and-mouth disease virus”. Virus Research 62:169-175, 1999.
A. Berinstein et al. “Antibodies to the Vitronectin Receptor (Integrin αvβ3) Inhibit Binding and Infection of Foot-and-Mouth Disease . . . ” Journal of Virology 69(4):2664-2666, Apr. 1995.
N. Parry et al. “Structural and serological evidence for a novel mechanism of antigenic variation in foot-and-mouth disease virus”. Letters to Nature 347:569-572, Oct. 11, 1990.
D. Logan et al. “Structure of a major immunogenic site on foot-and-mouth disease virus”. Letters to Nature 362:566-568, Apr. 8, 1993.
E. Fry et al. “The structure and function of a foot-and-mouth disease virus-oligosaccharide receptor complex”. EMBO Journal 18(3):543-554, 1999.
C. Carrillo et al. “Protective Immune Response to Foot-and-Mouth Disease Virus with VP1 Expressed in Transgenic Plants”. Journal of Virology 72(2):1688-1690, Feb. 1998.
R. DiMarchi et al. “Protection of Cattle Against Foot-and-Mouth Disease by a Synthetic Peptide”. Science 232:639-641, May 2, 1986.
A. Wigdorovitz et al. “Induction of a Protective Antibody Response to Foot and Mouth Disease Virus in Mice Following Oral or Parenteral Immunization . . . ” Virology 255:347-353, 1999.
A. Wigdorovitz et al. “Protection of Mice against Challenge with Foot and Mouth Disease Virus (FMDV) by Immunization with Foliar Extracts from Plants Infected . . . ” Virology 264:85-91, 1999.
T. Jackson et al. “Arginine-Glycine-Aspartic Acid-Specific Binding by Foot-and-Mouth Disease Viruses to the Purified Integrin αvβ3In Vitro”. Journal of Virology 71(11):8357-8361, Nov. 1997.
R. Acharya et al. “The three-dimensional structure of foot-and-mouth disease virus at 2.9 Å resolution”. Nature 337:709-716, Feb. 12, 1989.
S. Lea et al. “The structure and anigenicity of a type C foot-and-mouth disease virus”. Structure 2:123-139, Feb. 15, 1994.
J. Kluger. “Keep Foot-and-Mouth Disease Out of America: Crackdown on a Virus”. Time 36-37, Mar. 26, 2001.
G. de Prat-Gay. “Conformational Preferences of a Peptide Corresponding to the Major Antigenic Determinant of Foot-and-Mouth Disease Virus: Implications for Peptide Vaccine Approaches”. Archives of Biochemistry and Biophysics 341(2):360-369, 1997.
A. Benito et al. “Improved Mimicry of a Foot-and-Mouth Disease Virus Antigenic Site by a Viral Peptide Displayed . . . ” Biotechnology 13:801-802, Aug. 13, 1995.
D. M. Moore et al. “Identification of virus neutralizing epitopes on naturally occuring variants of type A12foot-and-mouth disease virus”. Virus Research 14:281-296, 1989.
S. J. Cox et al. “Emergency vaccination of sheep against foot-and-mouth disease: protection against disease and reduction in contact transmission”. Vaccine 17:1858-1868, 1999.
D. M. Perez Filgueira et al. “Effect ofMycobacteriumsp. Wall and Avridine on the antibody response, IgG isotype profile and proliferative response induced . . . ”. Vaccine 17:345-352, 1999.
D. M. Perez Filgueira et al. “Effect ofMycobacteriumsp. Wall and Avridine on the antibody response, IgG isotype profile and proliferative response . . . ”. Vaccine 17:345-352, 1999.
A. Berinstein et al. “Protective immunity against foot-and-mouth disease virus induced by a recombinant vaccinia virus”. Vaccine 18:2231-2238, 2000.
A. V. Iyer et al. “Evaluation of three ‘ready to formulate’ oil adjuvants for foot-and-mouth disease vaccine production”. Vaccine 19:1097-1105, 2001.
J. Ignacio Nunez et al. “A Single Amino Acid Substitution in Nonstructural Protein 3A Can Mediate Adaptation of Foot-and-Mouth . . . ”. Journal of Virology 75(8):3977-3983, Apr. 2001.
C. M. Ruiz-Jarabo et al. “Antigenic properties and population stability of a foot-and-mouth disease virus with an altered Arg-Gly-Asp . . . ”. Journal of General Virology 80:1899-1909, 1999.
F. Sobrino et al. “Antigenic variation of foot-and-mouth disease virus of serotype C during propagation in the field is mainly restricted to only one . . . ” Virus Research 14:273-280, 1989.
C. Carrillo et al. “Protective Immune Response to Foot-and-Mouth Disease Virus with VP1 Expressed in Transgenic Plants”. Journal of Virology 72(2):1688-1690, Feb. 1998.
A. Haghparast
Liang Shu-Mei
Shieh Jeng-Jer
Wang Jeng-Hwan
Academia Sinica
Campell Bruce R.
Fish & Richardson P.C.
Hill Myron G.
LandOfFree
VP1 of foot-and-mouth disease virus does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with VP1 of foot-and-mouth disease virus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and VP1 of foot-and-mouth disease virus will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3805929